Sign in
4

Changes in Ownership

ELITE PHARMACEUTICALS INC /NV/ Filed Acc 0001465825-12-000010

Director acquired 2,976,190 shares (conversion)

From the SEC's structured data for this filing

Trades in this filing

NARINE JEENARINE · Director

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2011-07-06 Conversion : show line 1 in the form +2,976,190 3,384,139 I

Table II: Derivative

2 lines
Date Transaction Shares Price Value Exercise Underlying Owned after D/I
2011-07-06 Conversion : show line 2 in the form Series E Convertible Preferred Stock −75 $1,000.00 $75,000 $0.03 2,976,190 2,978.5 I
2011-08-12 Purchase : show line 3 in the form Series E Convertible Preferred Stock +125 $1,000.00 $125,000 $0.02 5,040,323 3,112.5 I
Loading xslF345X03/primary_doc.xml…